[Therapeutic value of lymphadenectomy in ovarian cancer patients].
Ovarian cancer has the highest mortality rate among the female genital malignancies. Its incidence is steadily increasing worldwide, especially in highly industrialized countries. Scarce and non-specific clinical symptoms in the early stages, and lack of effective screening methods, are the reasons why in the majority of cases the disease is diagnosed in advanced stage. Early diagnosis and optimal therapeutic method have significant impact on the prognosis. Surgery remains the basic treatment method in all stages of ovarian cancer. The general principle is the removal of the entire tumor or maximal cytoreduction. Pelvic and para-aortic lymphadenectomy is an integral part of the operating protocol. Evaluation of the regional lymph nodes is an important element of the diagnosis in patients with ovarian cancer, as the disease stage and the decision about the method of adjuvant therapy both depend on it. The diagnostic value of lymphadenectomy is unquestionable and is the basis of proper classification, while its therapeutic value remains the subject of controversy. The aim of the paper is to review the results of the most important research concerning lymphadenectomy in ovarian cancer, based on the available literature.